Contattaci Contact Us

Dettagli dell'Evento:

Treatment of lung cancer in the era of precision medicine

Iscrizione:
Gratuita
Data:
30/04/2021
Luogo:
Sede:
Discipline::

In the last years progresses have been made in the field of non small cell lung cancer (NSCLC) tumor genomic with the discovery of biomolecular markers with about 20 of patients to date treated with targeted therapies according to specific genetic alterations.
New efforts are ongoing to identify new molecular targets and new drugs. Also the field of immunotherapy have been subjected to a huge step beyond with the development of a new class of the drugs the check point inhibitors. Recently single agent immunotherapy and the combination of chemo immunotherapy are the new standard of treatments for advanced NSCLC non oncogene addicted. The new frontiers of immunotherapy are represented by the combination of new immunotherapic agents. Some of the encoureging results observed in the metastatic setting have already been traslated in earlier stages of disease.
The rationale of the meeting is to deal with and discuss all these new standard treatments and their future developments and the new paradigms of the precision medicine.

Area riservata

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte



Nuovi Progetti: MINUTI DIGITALE



Minuti Menarini Online

Abbonati gratis alla rivista cartacea



Fondazione Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Menarini.

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484